Is RAONF or RYLD a better dividend investment in 2026?

RAONF currently yields 76.92% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RAONF offers higher current income.

What is the dividend yield difference between RAONF and RYLD?

RAONF has a forward dividend yield of 76.92% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 64.78 percentage points.

Home › Compare › RAONF vs RYLD

RAONF vs RYLD: Dividend Comparison 2026

RAONF yields 76.92% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RAONF wins by $1.40M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RAONF

● Live price

76.92%

Share price

$2.60

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.45M

Annual income

$406,212.55

Full RAONF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — RAONF vs RYLD

📍 RAONF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RAONF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RAONF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RAONF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RAONF

Annual income on $10K today (after 15% tax)

$6,538.46/yr

After 10yr DRIP, annual income (after tax)

$345,280.67/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RAONF beats the other by $343,081.42/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RAONF + RYLD for your $10,000?

RAONF: 50%RYLD: 50%

100% RYLD50/50100% RAONF

Portfolio after 10yr

$744.8K

Annual income

$204,399.94/yr

Blended yield

27.44%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RAONF buys

RYLD buys

No recent congressional trades found for RAONF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRAONFRYLD

Forward yield	76.92% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.45M	$44.5K ✓
Annual income after 10y	$406,212.55 ✓	$2,587.35
Total dividends collected	$1.25M	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RAONF vs RYLD ($10,000, DRIP)

Year	RAONF Portfolio	RAONF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$18,392	$7,692.31	$11,914	$1,213.65	+$6.5K → RAONF
2	$32,902	$13,222.36	$14,099	$1,351.30	+$18.8K → RAONF
3	$57,311	$22,106.15	$16,580	$1,494.55	+$40.7K → RAONF
4	$97,310	$35,987.08	$19,384	$1,642.61	+$77.9K → RAONF
5	$161,228	$57,105.82	$22,535	$1,794.70	+$138.7K → RAONF
6	$260,939	$88,425.56	$26,063	$1,950.00	+$234.9K → RAONF
7	$412,955	$133,749.94	$29,995	$2,107.69	+$383.0K → RAONF
8	$639,683	$197,821.28	$34,361	$2,266.99	+$605.3K → RAONF
9	$970,847	$286,385.73	$39,194	$2,427.12	+$931.7K → RAONF
10	$1,445,019	$406,212.55	$44,525	$2,587.35	+$1.40M → RAONF

RAONF vs RYLD: Complete Analysis 2026

RAONF — Stock

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.

Full RAONF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this RAONF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RAONF vs SCHD RAONF vs JEPI RAONF vs O RAONF vs KO RAONF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.